Literature DB >> 11337221

Antibiotic selective pressure and development of bacterial resistance.

M Kolár1, K Urbánek, T Látal.   

Abstract

This study evaluates the development of resistance in Gram-negative rods to cefotaxime and ceftazidime, ofloxacin and ciprofloxacin, gentamicin and amikacin, meropenem and ampicillin/sulbactam over a five year period of use (1994-1998) at the University Hospital in Olomouc, Czech Republic. The development of bacterial resistance was linked with antibiotic use and hence selective pressure which was specific for the type of antibiotic and the bacterial species. Statistically significant correlations were found for the use of ofloxacin and resistance in Escherichia coli, Proteus vulgaris and Providencia rettgeri; cefotaxime and Enterobacter cloacae; ceftazidime and Acinetobacter spp., Enterobacter agglomerans and Proteus vulgaris; and gentamicin and Proteus mirabilis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11337221     DOI: 10.1016/s0924-8579(01)00317-x

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  48 in total

1.  Tailored Antibacterials and Innovative Laboratories for Phage (Φ) Research: Personalized Infectious Disease Medicine for the Most Vulnerable At-Risk Patients.

Authors:  Austen L Terwilliger; Carmen Gu Liu; Sabrina I Green; Justin R Clark; Keiko C Salazar; Haroldo Hernandez Santos; Emmaline R Heckmann; Barbara W Trautner; Robert F Ramig; Anthony W Maresso
Journal:  Phage (New Rochelle)       Date:  2020-06-16

2.  Antimicrobial Use for and Resistance of Zoonotic Bacteria Recovered from Nonhuman Primates.

Authors:  Jeffrey Kim; Dondrae J Coble; Gregory W Salyards; Julie K Bower; William J Rinaldi; Gail B Plauche; Gregory G Habing
Journal:  Comp Med       Date:  2017-02-01       Impact factor: 0.982

3.  Phage-Related Ribosomal Protease (Prp) of Staphylococcus aureus: In Vitro Michaelis-Menten Kinetics, Screening for Inhibitors, and Crystal Structure of a Covalent Inhibition Product Complex.

Authors:  Julia A Hotinger; Heather A Pendergrass; Darrell Peterson; H Tonie Wright; Aaron E May
Journal:  Biochemistry       Date:  2022-06-22       Impact factor: 3.321

4.  Changing Trend in the Antibiotic Resistance Pattern of Pseudomonas Aeruginosa Isolated from Wound Swabs of Out-Patients and in-Patients of a Tertiary Care Hospital.

Authors:  Noyal Mariya Joseph; Sheela Devi; P Shashikala; Reba Kanungo
Journal:  J Clin Diagn Res       Date:  2013-10-05

5.  Evolution of drug-resistant and virulent small colonies in phenotypically diverse populations of the human fungal pathogen Candida glabrata.

Authors:  Sarah J N Duxbury; Steven Bates; Robert E Beardmore; Ivana Gudelj
Journal:  Proc Biol Sci       Date:  2020-07-15       Impact factor: 5.349

6.  Influencing the use of antibiotics in a Chinese pediatric intensive care unit.

Authors:  Hui Ding; Yonghong Yang; Jinghai Wei; Shaozhen Fan; Sangjie Yu; Kaihu Yao; Aihua Wang; Xuzhuang Shen
Journal:  Pharm World Sci       Date:  2008-05-21

7.  Impact of a multidisciplinary approach on antibiotic consumption, cost and microbial resistance in a Czech hospital.

Authors:  Rene Mach; Jiri Vlcek; Miroslava Prusova; Petr Batka; Vladan Rysavy; Ales Kubena
Journal:  Pharm World Sci       Date:  2007-07-04

Review 8.  Ethnobotany and the Role of Plant Natural Products in Antibiotic Drug Discovery.

Authors:  Gina Porras; François Chassagne; James T Lyles; Lewis Marquez; Micah Dettweiler; Akram M Salam; Tharanga Samarakoon; Sarah Shabih; Darya Raschid Farrokhi; Cassandra L Quave
Journal:  Chem Rev       Date:  2020-11-09       Impact factor: 60.622

9.  Antibiotic Resistance of Escherichia coli Serotypes from Cochin Estuary.

Authors:  Divya P Sukumaran; Srinivasan Durairaj; Mohamed Hatha Abdulla
Journal:  Interdiscip Perspect Infect Dis       Date:  2012-09-12

10.  Compliance of antibiotics used for surgical site infection prophylaxis among patients undergoing surgery in a Congolese teaching hospital.

Authors:  Gabriel Kambale Bunduki; Michel Paluku Mukululi; Claude Kasereka Masumbuko; Séverin Akinja Uwonda
Journal:  Infect Prev Pract       Date:  2020-07-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.